Related Experiment Videos
Morphological changes in leukemic lymphoblasts and normal lymphocytes treated with deoxyadenosine plus
Cancer Investigation
|January 1, 1985
Summary
Inborn adenosine deaminase (ADA) deficiency and deoxycoformycin treatment cause lympholysis. In vitro studies show deoxyadenosine plus deoxycoformycin induces T-lymphoblast cell death via specific morphological changes.
Area of Science:
- Biochemistry
- Immunology
- Cell Biology
Background:
- Lympholysis in adenosine deaminase (ADA) deficiency and deoxycoformycin treatment remains poorly understood.
- In vitro models are crucial for studying the mechanisms of lympholysis.
Purpose of the Study:
- To investigate the in vitro mechanisms of lympholysis induced by ADA inhibition.
- To characterize the morphological and metabolic changes preceding cell death in lymphoid cells.
Main Methods:
- Treatment of T-lymphoblast and B-lymphoblast cell lines with deoxyadenosine and deoxycoformycin.
- Morphological analysis using microscopy.
- Assessment of DNA synthesis and cellular ATP levels.
Main Results:
- Deoxyadenosine plus deoxycoformycin induced nuclear fragmentation, chromatin disintegration, and cytoplasmic blebbing in T-lymphoblasts, but not B-lymphoblasts.
- Morphological changes correlated with growth inhibition sensitivity.
- These energy-dependent changes were preceded by DNA synthesis inhibition and dATP accumulation, followed by ATP depletion and cell lysis.
Conclusions:
- The observed morphological changes represent an energy-dependent intermediate step between metabolic alterations and lympholysis in ADA-deficient or treated lymphoid cells.
- T-lymphoblasts are more susceptible to deoxyadenosine plus deoxycoformycin-induced lympholysis than B-lymphoblasts.